Skip to main content
. 2022 Mar 28;22:150. doi: 10.1186/s12876-022-02219-8

Table 2.

Previous cases of PI/PCI post etoposide-based chemotherapy

Case [Ref.] Sex/Age (yr) Underlying disease Chemotherapy Causative agent, dose Location Diagnostic tools Associated symptoms Complications Treatments Outcome Time to recovery
1 [29] M/58 Lymphoma NA Etoposide, NA Total colon X-ray + CT None No Parenteral nutrition antibiotics Resolved 30 days
2 [32] M/51 Lymphoma MNCOP-V Etoposide, 100 mg Total colon X-ray Septicemia and abdominal discomfort No Oxygen therapy parental nutrition antibiotics Resolved NA
3 [32] F/58 Lymphoma MNCOP-V Etoposide, 95 mg Total colon + terminal ileum X-ray Slight abdominal distension No Oxygen therapy parental nutrition Resolved 1 week
4 [32] M/74 AML-M2 NA Etoposide, NA Total colon X-ray Abdominal distension No Oxygen therapy parental nutrition Resolved 2 weeks
5 [34] F/53 Breast cancer Various Etoposide, 50 mg qd Total colon + rectum X-ray + CT + colonoscopy Severe abdominal distension with decreased flatus No Oxygen therapy antibiotics Resolved 3 weeks
6 [35] M/69 Small cell lung cancer Carboplatin (d1) + etoposide (d1–3) Etoposide, 100 mg Sigmoid colon + retroperitoneum + posterior mediastinum CT Abdominal distension No Oxygen therapy antibiotics Resolved 2 weeks

M male, F female, AML acute myeloid leukemia, MNCOP-V methotrexate with leucovorin rescue, mitoxantrone, cyclophosphamide, vincristine, prednisolone and etoposide, NA not available